329 filings
8-K
GALT
Galectin Therapeutics Inc
29 Mar 24
Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update
7:55am
8-K
GALT
Galectin Therapeutics Inc
11 Dec 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
GALT
Galectin Therapeutics Inc
7 Dec 23
Regulation FD Disclosure
11:42am
8-K
GALT
Galectin Therapeutics Inc
13 Nov 23
Results of Operations and Financial Condition
7:55am
8-K
GALT
Galectin Therapeutics Inc
14 Aug 23
Results of Operations and Financial Condition
7:55am
8-K
qmyzpj
15 May 23
Results of Operations and Financial Condition
7:55am
8-K
wbu 7tljvon4
30 Mar 23
Galectin Therapeutics Reports 2022 Financial Results and Provides Business Update
7:54am
8-K
ccgva1
2 Mar 23
Other Events
7:55am
8-K
ze4ad ax3bvrzv63cpe
5 Jan 23
Other Events
7:55am
8-K
yjp0 t08zr5ggd
6 Dec 22
Submission of Matters to a Vote of Security Holders
8:00am
8-K
cdmu9g gah4qryya
1 Dec 22
Regulation FD Disclosure
11:00am
8-K
uc38m8kc677b2 tuwee
14 Nov 22
Results of Operations and Financial Condition
7:55am
8-K
ji4fh 70oe0
12 Oct 22
Galectin Therapeutics Receives FDA Approval to Proceed with Combination Immunotherapy Trial in Head and Neck Cancer
7:50am
8-K
t5zn1jl0kzn6
6 Oct 22
Other Events
7:50am
8-K
f8rwi
15 Aug 22
Results of Operations and Financial Condition
7:56am
8-K
qj5l0teng4ifsstk9
26 Jul 22
Galectin Therapeutics Announces $60 Million Credit Line
7:57am
8-K
p1qfqq
16 May 22
Results of Operations and Financial Condition
7:55am
8-K
jxljai8utdf7jboare
14 Apr 22
Other Events
7:50am
8-K
3pg7vaz7ici9n8twmxx
31 Mar 22
Galectin Therapeutics Reports 2021 Financial Results and Provides Business Update
8:06am
8-K
u8nuiigkdhuucz
21 Dec 21
Galectin Therapeutics Announces Closing of $10 Million in Debt Financing from Its Chairman, Richard E. Uihlein
7:50am